Coagulation parameters predict COVID-19-related thrombosis in a neural network with a positive predictive value of 98

Romy de Laat-Kremers1, Raf De Jongh2,3, Marisa Ninivaggi4

  • 1Department of Data Analysis and Artificial Intelligence, Synapse Research Institute, Maastricht, Netherlands.

Frontiers in Immunology
|October 17, 2022
PubMed

Insights

A new neural network accurately predicts COVID-19-related thrombosis using patient data. This tool aids in identifying patients at risk for dangerous blood clots during hospitalization.

Area of Science:

  • * Hematology and Thrombosis
  • * Infectious Disease Pathogenesis
  • * Artificial Intelligence in Medicine

Background:

  • * Thrombosis is a significant complication of COVID-19, linked to alterations in coagulation factors.
  • * Predicting COVID-19 thrombosis is challenging due to its multifactorial nature and the inadequacy of single hemostatic variables.
  • * Understanding the coagulation system's role is crucial for managing COVID-19 complications.

Purpose of the Study:

  • * To develop and validate a predictive model for COVID-19-related thrombosis.
  • * To identify key hemostatic and laboratory variables for thrombosis prediction.
  • * To improve early detection and management of thrombotic events in COVID-19 patients.

Main Methods:

  • * Development of a neural network using hemostatic and laboratory data from 149 COVID-19 patients across two cohorts.
  • * Validation of the neural network on patient data collected at hospital and ICU admission.
  • * Analysis of variable importance for predicting thrombosis.

Main Results:

  • * The neural network identified key predictors including C-reactive protein, sex, and various thrombin generation parameters.
  • * The model demonstrated high predictive accuracy, achieving a positive predictive value of 98%-100% for COVID-19-related thrombosis.
  • * The model effectively predicts thrombosis risk at the time of hospital admission.

Conclusions:

  • * A validated neural network can accurately predict COVID-19-related thrombosis.
  • * The model utilizes a combination of hemostatic and general laboratory variables for prediction.
  • * This tool offers a promising approach for early identification and prevention of thrombosis in COVID-19 patients.

Related Concept Videos

Coagulation01:09

Coagulation

The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
7.2K
Sensitivity, Specificity, and Predicted Value01:13

Sensitivity, Specificity, and Predicted Value

In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
Sensitivity is the...
611
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
854